JM, Z., JS, S., AA, D., EK, M., MD, S., G, P., . . . PM, T. (2021). Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants. Advanced therapeutics, 4(8), 2100099. https://doi.org/10.1002/adtp.202100099
Chicago Style (17th ed.) CitationJM, Zupancic, et al. "Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants." Advanced Therapeutics 4, no. 8 (2021): 2100099. https://doi.org/10.1002/adtp.202100099.
MLA (9th ed.) CitationJM, Zupancic, et al. "Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants." Advanced Therapeutics, vol. 4, no. 8, 2021, p. 2100099, https://doi.org/10.1002/adtp.202100099.
Warning: These citations may not always be 100% accurate.